Outcomes from rectal vancomycin therapy in patients with clostridium difficile infection

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 924-925

  Saffouri, George ^a   Khanna, Sahil ^a   Estes, Lynn ^a   Pardi, Darrell ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

CLINICAL ARTICLE; CLOSTRIDIUM INFECTION; COHORT ANALYSIS; COLON RESECTION; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE; LETTER; LEUKOCYTE COUNT; MALE; PARALYTIC ILEUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHOCK; TOXIC MEGACOLON; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, RECTAL; AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DRUG THERAPY, COMBINATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; METRONIDAZOLE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84901992414     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.80     Document Type: Letter

References (5)

1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium diffi cile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31;431-55
2. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium diffi cile infections. Am J Gastroenterol 2013;108;| 478-98
3. Fekety R, Shah AB. Diagnosis and treatment of Clostridium diffi cile colitis. JAMA 1993;269;71-5. (Pubitemid 23006526
4. Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium diffi cile colitis: Case series and review of the literature. Clin Infect Dis 2002;35;690-6. (Pubitemid 35024729
5. Olson MM, Shanholtzer CJ, Lee JT Jr, et al. Ten years of prospective Clostridium diffi cile-Associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15;371-81